REGENERON PHARMACEUTICALS, INC.

institutionalUpdated 34 days ago

Managed by Regeneron Pharmaceuticals, Inc. • Latest filing Q2 2026

Portfolio value

$177.2M

Q2 2026

Filings

Quarterly 13F history

Top-10 concentration

100.0%

Weight of largest holdings

Annualized return

-96.9%

Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 7 quarters

Show data table

3 positions as of Q2 2026

#	Stock	Value	Shares	% Portfolio	Change
1	P PBLS Parabilis Medicines, Inc.	$114M	4.17M	64.35%	—
2	N NTLA Intellia Therapeutics, Inc.	$62.7M	3.70M	35.35%	—
3	A ACET Adicet Bio, Inc.	$523K	60.5K	0.29%	—

Parabilis Medicines, Inc.

Value

$114M

4.17M

% Port

64.35%

Intellia Therapeutics, Inc.

Value

$62.7M

3.70M

% Port

35.35%

Adicet Bio, Inc.

Value

$523K

60.5K

% Port

0.29%